| dc.contributor.author | Gonda Xénia | |
| dc.contributor.author | Eszlári Nóra | |
| dc.contributor.author | Anderson IM | |
| dc.contributor.author | Deakin JF | |
| dc.contributor.author | Bagdy György | |
| dc.contributor.author | Juhász Gabriella | |
| dc.date.accessioned | 2018-03-03T10:46:51Z | |
| dc.date.available | 2018-03-03T10:46:51Z | |
| dc.date.issued | 2016 | |
| dc.identifier | 85038006223 | |
| dc.identifier.citation | pagination=e945, 8 pages; journalVolume=6; journalIssueNumber=11; journalTitle=TRANSLATIONAL PSYCHIATRY; | |
| dc.identifier.uri | http://repo.lib.semmelweis.hu//handle/123456789/4992 | |
| dc.identifier.uri | doi:10.1038/tp.2016.221 | |
| dc.description.abstract | Current understanding and treatment of depression is limited to the monoaminergic theory with little knowledge of the involvement of other cellular processes. Genome-wide association studies, however, implicate several novel single-nucleotide polymorphisms with weak but replicable effects and unclarified mechanisms. We investigated the effect of rs1106634 of the ATPV1B2 gene encoding the vacuolar H+ATPase on lifetime and current depression and the possible mediating role of neuroticism by logistic and linear regression in a white European general sample of 2226 subjects. Association of rs1106634 with performance on frontal (Stockings of Cambridge (SOC)) and hippocampal-dependent (paired associates learning (PAL)) cognitive tasks was investigated in multivariate general linear models in a smaller subsample. The ATP6V1B2 rs1106634 A allele had a significant effect on lifetime but not on current depression. The effect of the A allele on lifetime depression was not mediated by neuroticism. The A allele influenced performance on the PAL but not on the SOC test. We conclude that the effects of variation in the vacuolar ATPase may point to a new molecular mechanism that influences the long-term development of depression. This mechanism may involve dysfunction specifically in hippocampal circuitry and cognitive impairment that characterizes recurrent and chronic depression. | |
| dc.title | Association of ATP6V1B2 rs1106634 with lifetime risk of depression and hippocampal neurocognitive deficits: possible novel mechanisms in the etiopathology of depression | |
| dc.type | Journal Article | |
| dc.date.updated | 2018-02-23T08:25:16Z | |
| dc.language.rfc3066 | en | |
| dc.identifier.mtmt | 3138408 | |
| dc.identifier.wos | 000392132700006 | |
| dc.identifier.pubmed | 27824360 | |
| dc.contributor.department | SE/GYTK/GYHATAS/NAP-A-SE Új Antidepresszív Gyógyszercélpont Kutatócsoport | |
| dc.contributor.department | SE/AOK/K/Pszichiátriai és Pszichoterápiás Klinika | |
| dc.contributor.department | SE/GYTK/GYHATAS/MTA-SE Neuropszichofarmakológiai és Neurokémiai Kutatócsoport | |
| dc.contributor.department | SE/GYTK/Gyógyszerhatástani Intézet | |
| dc.contributor.institution | Semmelweis Egyetem |